Product NewsLife Sciences NascaCell Technologies AG and the University of Massachusetts develop Aptamers and Microbodies™ against Botulinum toxin (Botox)
Product NewsLife Sciences NascaCell Technologies AG and Boehringer Ingelheim sign collaboration agreement on therapeutic Microbodies™